New hope for slowing kidney damage in patients who Can't take standard drugs
NCT ID NCT07181135
Summary
This study is testing whether a daily pill called finerenone can help slow the progression of chronic kidney disease in adults who are not taking standard medications called RAS inhibitors. About 180 participants will be randomly assigned to take either finerenone or a placebo pill for six months. Researchers will measure changes in a urine protein called albumin to see if the drug helps protect kidney function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clínica Universidad de Navarra
Madrid, Spain
-
Clínica Universidad de Navarra
Pamplona, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, Spain
-
Hospital Universitari Germans Trias i Pujol
Barcelona, Spain
-
Hospital Universitario Dr Peset
Valencia, Spain
-
Hospital Universitario Puerta de Hierro
Madrid, Spain
-
Hospital Universitario de La Princesa
Madrid, Spain
-
Vall d'Hebron University Hospital
Barcelona, Spain
Conditions
Explore the condition pages connected to this study.